Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
Page 6 of 8
Mar 2, 2026Health Gorilla, a health data aggregator, has filed a motion to dismiss a lawsuit brought by Epic Systems and several healthcare providers. The case centers on allegations regarding the inappropriate access to nearly 300,000 patient records and underscores the complexities in national health data sharing, governance, and regulatory frameworks.
Sophia Reynolds
Feb 22, 2026The integration of AI into nursing education is setting new standards for what is expected of graduating nurses. Early immersion in AI tools fosters adaptability and proficiency, empowering nurses to deliver high-quality care in technologically advanced healthcare environments.
Emily Carter
Feb 21, 2026Mercyhealth’s integration of Arintra’s AI-powered medical coding solution has notably improved financial performance by streamlining coding automation, identifying documentation gaps, and customizing claims to specific payers, underscoring the transformative potential of AI in healthcare revenue cycles.
Dr. Priya Nandakumar
Feb 20, 2026The recent $10 billion acquisition of Masimo by Danaher marks a significant consolidation in the medical diagnostics sector. This strategic acquisition aims to enhance Danaher’s diagnostic capabilities and expand its footprint in acute care settings, highlighting an industry-wide shift towards integrated care and continuous clinical data collection inside hospitals.
Daniel Cho
Feb 19, 2026Patients navigating healthcare often face challenges with outdated or inaccurate lists of providers. The national provider directory, slated for launch this year, promises to centralize and standardize information about doctors and hospitals. This initiative could revolutionize healthcare navigation and decision-making for patients and providers alike.
Sophia Reynolds
Feb 12, 2026Mount Sinai’s decision to adopt Dragon Copilot highlights ongoing shifts in healthcare technology towards integrated AI solutions for clinical documentation. This move underscores the importance of interoperability and real-time ambient AI assistance in streamlining physician workflows.
Emily Carter
Feb 5, 2026Jake Leach assumed leadership of DexCom with a mission to revitalize the company’s impact in diabetes management. He advocates that type 2 diabetics on GLP-1 weight loss drugs should also utilize CGMs, reflecting a growing intersection of diabetes technologies and therapies. This perspective highlights the evolving standards in diabetes care and DexCom’s innovative role within it.
Dr. Alex Morgan
Feb 3, 2026Dextrocardia is a rare congenital condition characterized by the heart and organs being reversed from their usual position. While rare, congenital heart defects are common and can vary in severity and impact. This article discusses the clinical perspectives on dextrocardia, its epidemiology, and implications for health.
Dr. Priya Nandakumar
Jan 30, 2026As digital care continues to transform healthcare delivery, Maven Clinic’s research institute represents a strategic effort to assess and amplify the impact of such innovations. This analytic post explores the institute's mission, expected contributions, and potential implications for women’s and family health.
Dr. Priya Nandakumar
Jan 30, 2026The dispute between Epic Systems and Health Gorilla goes beyond a single lawsuit, reflecting broader tensions within healthcare’s evolving digital landscape. This article examines the implications of this case for medical record control, data sharing protocols, and regulatory frameworks in healthcare IT.
Dr. Priya Nandakumar
Jan 29, 2026NOCD’s strategic move to create a parent brand, Noto, marks a significant expansion of its virtual mental health services. With the acquisition of Rebound Health, it aims to address complex conditions like PTSD alongside OCD, reflecting broader trends in digital mental health care innovation.
Daniel Cho
Jan 27, 2026Early cancer detection remains a critical challenge in oncology, with significant implications for patient outcomes and healthcare costs. Endeavor Health's investigation into blood-based multi-cancer detection tests represents a pivotal step towards wider clinical adoption of these emerging technologies.
Dr. Priya NandakumarMachine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.